18,389 Shares in The Cooper Companies, Inc. $COO Acquired by PEAK6 LLC

PEAK6 LLC bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 18,389 shares of the medical device company’s stock, valued at approximately $1,319,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares in the last quarter. Avalon Trust Co bought a new position in Cooper Companies during the second quarter worth $25,000. SJS Investment Consulting Inc. boosted its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. Elevation Wealth Partners LLC grew its holdings in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after purchasing an additional 375 shares during the period. Finally, J.Safra Asset Management Corp acquired a new stake in Cooper Companies in the second quarter worth $32,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of several research reports. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. JPMorgan Chase & Co. reduced their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. Needham & Company LLC dropped their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Finally, UBS Group began coverage on Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Price Performance

COO stock opened at $76.22 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The business has a 50-day simple moving average of $71.93 and a two-hundred day simple moving average of $71.09. The company has a market capitalization of $14.87 billion, a P/E ratio of 64.59, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.